Lead Clinical Scientist – End-to-End Studies (Hybrid)

CSL; Thatcham; Hybrid; GBP 90,000 - 130,000; Full time

Job summary

CSL Seqirus is seeking a Principal Clinical Scientist hybrid role, based in Maidenhead, with global collaboration across US and Australia. You will lead studies end-to-end—from protocol development, start-up, execution, data interpretation, to close-out with the clinical study report.

Strong CRO partnership and regulatory submission experience are preferred. This role emphasizes scientific leadership within a full-outsource operating model, not routine in-house trial activity, and offers

Qualifications

• Hands-on experience with clinical studies from protocol development to close-out
• Experience writing clinical study protocols and clinical study reports
• Experience working in a full-outsource/CRO-dependent operating model

Responsibilities

• Lead all scientific elements of clinical studies from protocol development through study execution to a final clinical study report
• Write and/or take responsibility for study protocols, clinical study reports and other critical study documents
• Manage day-to-day relationships with CROs under a full-outsource operating model
• Collaborate with cross-functional study teams
• Contribute to the scientific interpretation of clinical data and supporting documentation
• Build relationships across the wider team including US and Australia

Skills

Clinical studies

Protocol development

Study execution

Clinical study reports

CRO management

Cross-functional collaboration

Job description

CSL Seqirus is seeking a Principal Clinical Scientist hybrid role, based in Maidenhead, with global collaboration across US and Australia. You will lead studies end-to-end—from protocol development, start-up, execution, data interpretation, to close-out with the clinical study report.

Strong CRO partnership and regulatory submission experience are preferred. This role emphasizes scientific leadership within a full-outsource operating model, not routine in-house trial activity, and offers